Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Clinical trial NCT07143669 · RECRUITING

Trial details

NCT number: NCT07143669
Sponsor: Blueprint Medicines Corporation
Status: RECRUITING
Study type: OBSERVATIONAL

Clonal Mast Cell Disease KIT D816V Mutation Suspected KITD816V Mutated Clonal Mast Cell Disease

Start date: 2025-10-17
Primary completion: 2028-07-31
Enrollment: 750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.